Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), bought 6,900 shares at $13.01 ($90K) on 2006-05-08, disclosed to the SEC on 2006-05-10.
Open-market purchase of $90k SLXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.01 | 900 | $12K | 13.0% |
| 2 | $13.01 | 5,000 | $65K | 72.4% |
| 3 | $13.03 | 1,000 | $13K | 14.5% |
| Total | $13.01 avg | 6,900 | $90K | 100% |
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |